Close Menu

University of Melbourne

Replacing nasopharyngeal swabs with saliva samples or nasal swabs could increase throughput and convenience, as well as relieve reagent and equipment shortages.

The project, the first under a partnership between the university and Illumina announced last year, will apply whole-genome sequencing to challenging cancers types.

An Australian team developed a decision model for testing asymptomatic relatives of patients with dilated cardiomyopathy to assess the cost effectiveness of testing.

The partners are aiming to broaden the applicability of Genetic Technologies' BrevaGenplus breast cancer risk assessment test.

The partners will evaluate new biomarkers that they both find, and will assess the possibility for a preterm birth prognostic panel.